LIS
CLBT icon

Legacy Investment Solutions’s Cellebrite CLBT Stock Holding History

Legacy Investment Solutions’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$534 Buy
+21
New +$404 ﹤0.01% 655

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
CC
Crosslink Capital Menlo Park, California $1.35B AUM 35.86% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Legacy Investment Solutions's CLBT Position: Q4 2024 in Review

Legacy Investment Solutions opened a new position in Cellebrite (CLBT) in Q4 2024: 21 shares worth $534. The stake represents ﹤0.01% of the portfolio and ranks #655 among its holdings.

191 funds tracked by Wall St. Rank hold CLBT as of Q4 2024.

  • Legacy Investment Solutions held 21 shares of Cellebrite worth $534 as of Q4 2024.
  • Cellebrite was a new Legacy Investment Solutions position in Q4 2024.
  • Cellebrite made up ﹤0.01% of Legacy Investment Solutions's portfolio in Q4 2024, its #655 holding.
  • 191 funds tracked by Wall St. Rank held Cellebrite as of Q4 2024.

Based on Legacy Investment Solutions's 13F filing for Q4 2024, filed 14 Feb 2025.